Next Issue
Volume 1, December
 
 

Pharmaceuticals, Volume 1, Issue 1 (January 2004) – 1 article , Pages 1-30

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
435 KiB  
Review
Specific Selection of Essential Oil Compounds for Treatment of Children’s Infection Diseases
by Alexander Pauli and Heinz Schilcher
Pharmaceuticals 2004, 1(1), 1-30; https://0-doi-org.brum.beds.ac.uk/10.3390/pharm01010001 - 27 Jan 2004
Cited by 39 | Viewed by 10651
Abstract
Preparations with essential oils and their dosages applied in the therapy of children’s infectious diseases are well documented. In contrast, information is only sparingly available about uses of isolated pure essential oil compounds for the treatment of such infections. To find out safe [...] Read more.
Preparations with essential oils and their dosages applied in the therapy of children’s infectious diseases are well documented. In contrast, information is only sparingly available about uses of isolated pure essential oil compounds for the treatment of such infections. To find out safe antimicrobials from essential oils, microbiological inhibitory data of children pathogens were combined with oral and dermal acute toxicity data to calculate oral and dermal therapeutical indices (TI). The superiority of antibiotic drugs became obvious following calculating oral TIs of antimicrobials from higher plants, which suggests that oral administrations of essential oil compounds are not suitable to cure severe infections. A few selected compounds from higher plants show moderate effectiveness against gram-positive bacteria, yeast and fungi, but not gram-negative bacteria. Topical application or inhalation of selected compounds for the treatment or additional treatment of mild infections is reasonable. Full article
Show Figures

Graphical abstract

Next Issue
Back to TopTop